122 related articles for article (PubMed ID: 6194983)
1. Inhibition of phospholipase A2 by gabexate mesilate, camostate and aprotinine.
Freise J; Magerstedt P; Schmid K
Enzyme; 1983; 30(3):209-12. PubMed ID: 6194983
[TBL] [Abstract][Full Text] [Related]
2. In vitro inhibition of phospholipase A2 by gabexate mesilate, camostate, and aprotinine.
Freise J; Wittenberg H; Magerstedt P
Klin Wochenschr; 1989 Feb; 67(3):149-52. PubMed ID: 2467043
[TBL] [Abstract][Full Text] [Related]
3. Gabexate mesilate and camostate: new inhibitors of phospholipase A2 and their influence on the alpha-amylase activity in serum of patients with acute pancreatitis.
Freise J; Schmidt FW; Magerstedt P; Schmid K
Clin Biochem; 1985 Aug; 18(4):224-9. PubMed ID: 2412725
[TBL] [Abstract][Full Text] [Related]
4. Effects of the serine protease inhibitor gabexate mesilate on purified pancreatic phospholipase A2.
Hesse B; Lankisch PG; Kunze H
Pharmacol Res Commun; 1984 Jul; 16(7):637-45. PubMed ID: 6433363
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of porcine pancreas phospholipase A2 activation by gabexate mesilate.
Schädlich HR; Büchler M; Beger HG
Klin Wochenschr; 1989 Feb; 67(3):160-2. PubMed ID: 2494376
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effect of gabexate mesilate on pancreatic phospholipase A2-mediated hydrolysis of ghost membranes.
Nishijima J; Okamoto M; Nakaguchi K; Ogawa M; Yamano T; Mori T
Gen Pharmacol; 1985; 16(3):177-82. PubMed ID: 3926598
[TBL] [Abstract][Full Text] [Related]
7. Effects of the serine protease inhibitors FOY and FOY 305 on phospholipase A1 (EC 3.1.1.32) activity in rat - liver lysosomes.
Kunze H; Bohn E
Pharmacol Res Commun; 1983 May; 15(5):451-9. PubMed ID: 6412250
[TBL] [Abstract][Full Text] [Related]
8. Influence of aprotinin and gabexate mesilate on arachidonic acid release by the Ca-ionophore A 23187 in the lung.
Seeger W; Wolf H; Graubert E; Moser U; Neuhof H; Roka L
Adv Exp Med Biol; 1983; 156():553-67. PubMed ID: 6190378
[TBL] [Abstract][Full Text] [Related]
9. Effects of the anti-inflammatory serine esterase inhibitor, FOY, on phospholipase A2 (EC 3.1.1.4) activity in rabbit polymorphonuclear leukocytes.
Kunze H; Bohn E; Damerau B
Pharmacol Res Commun; 1983 Oct; 15(9):869-78. PubMed ID: 6417683
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of acute pancreatitis with a synthetic protease and phospholipase A2 inhibitor gabexate mesilate].
Freise J
Fortschr Med; 1983 Aug; 101(31-32):1432-6. PubMed ID: 6194089
[TBL] [Abstract][Full Text] [Related]
11. [Effect of FOY-305 on the activity and secretion of pancreatic enzymes in vitro].
Stöckmann F; Göke B; Otto J; Lankisch PG; Creutzfeldt W
Z Gastroenterol; 1984 Jun; 22(6):311-7. PubMed ID: 6205521
[TBL] [Abstract][Full Text] [Related]
12. Cellular (thrombocytes, granulocytes) effects of proteinase inhibitors--gabexylate, gabexate mesilate (FOY) and aprotinin.
Redl H; Schlag G; Paul E; Schiesser A
Resuscitation; 1986 Sep; 14(1-2):81-90. PubMed ID: 2431445
[TBL] [Abstract][Full Text] [Related]
13. [Phospholipase A2 inhibitors in hemorrhagic-necrotizing pancreatitis. Animal experiment evaluation of a new treatment concept].
Kahle M; Klein U; König W; Martin U; Alles JU
Z Gastroenterol; 1985 Dec; 23(12):687-93. PubMed ID: 3937346
[TBL] [Abstract][Full Text] [Related]
14. FOY: [ethyl p-(6-guanidinohexanoyloxy) benzoate] methanesulfonate as a serine proteinase inhibitor. II. In vivo effect on coagulofibrinolytic system in comparison with heparin or aprotinin.
Ohno H; Kambayashi J; Chang SW; Kosaki G
Thromb Res; 1981 Dec 1-15; 24(5-6):445-52. PubMed ID: 6178174
[No Abstract] [Full Text] [Related]
15. Inhibitory effect of aprotinin and gabexate mesilate on human plasma kallikrein.
Nakahara M
Arzneimittelforschung; 1983; 33(7):969-71. PubMed ID: 6194800
[TBL] [Abstract][Full Text] [Related]
16. [Comparative studies of nafamostat mesilate and various serine protease inhibitors in vitro].
Ino Y; Suzuki K; Sato T; Iwaki M
Nihon Yakurigaku Zasshi; 1986 Dec; 88(6):449-55. PubMed ID: 2435641
[TBL] [Abstract][Full Text] [Related]
17. Lysolecithin concentration in pancreatic tissue during therapy with phospholipase A2-inhibitors in acute necrotizing pancreatitis.
Kahle M; König H; Filler RD
Klin Wochenschr; 1989 Feb; 67(3):177-9. PubMed ID: 2494378
[TBL] [Abstract][Full Text] [Related]
18. Effects of antiproteases (aprotinin and gabexate-mesilate) on the postischemic vascular response of the kidney.
Pflüger H; Maier M; Binder BR
Urol Int; 1983; 38(3):150-7. PubMed ID: 6191420
[TBL] [Abstract][Full Text] [Related]
19. Gabexate mesilate (FOY) and aprotinin. A comparative study of the effects on trypsin-induced activation of the kinin and complement systems in vivo and in vitro.
Lasson A; Balldin G; Ohlsson K
Hoppe Seylers Z Physiol Chem; 1984 Dec; 365(12):1409-15. PubMed ID: 6084637
[TBL] [Abstract][Full Text] [Related]
20. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
